HOLLENCREST CAPITAL MANAGEMENT - CANOPUS BIOPHARMA INC ownership

CANOPUS BIOPHARMA INC's ticker is and the CUSIP is 138034103. A total of 1 filers reported holding CANOPUS BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HOLLENCREST CAPITAL MANAGEMENT ownership history of CANOPUS BIOPHARMA INC
ValueSharesWeighting
Q3 2022$4,0000.0%80,0000.0%0.00%
Q2 2022$4,000
+33.3%
80,0000.0%0.00%
Q1 2022$3,000
-72.7%
80,0000.0%0.00%
-100.0%
Q4 2021$11,000
+175.0%
80,0000.0%0.00%
Q3 2021$4,000
-80.0%
80,0000.0%0.00%
-100.0%
Q2 2021$20,000
+5.3%
80,0000.0%0.00%0.0%
Q1 2021$19,000
+533.3%
80,0000.0%0.00%
Q4 2020$3,000
+50.0%
80,0000.0%0.00%
Q3 2020$2,000
+100.0%
80,0000.0%0.00%
Q2 2020$1,000
-90.0%
80,0000.0%0.00%
-100.0%
Q1 2020$10,0000.0%80,0000.0%0.00%0.0%
Q4 2019$10,000
-37.5%
80,0000.0%0.00%
-50.0%
Q3 2019$16,000
+23.1%
80,0000.0%0.00%0.0%
Q2 2019$13,000
+44.4%
80,0000.0%0.00%
+100.0%
Q1 2019$9,0000.0%80,0000.0%0.00%0.0%
Q4 2018$9,0000.0%80,0000.0%0.00%0.0%
Q3 2018$9,000
-73.5%
80,0000.0%0.00%
-80.0%
Q2 2018$34,000
+325.0%
80,0000.0%0.01%
+400.0%
Q1 2018$8,000
-55.6%
80,0000.0%0.00%
-50.0%
Q4 2017$18,000
+50.0%
80,0000.0%0.00%0.0%
Q3 2017$12,000
-72.7%
80,0000.0%0.00%
-71.4%
Q2 2017$44,000
+83.3%
80,0000.0%0.01%
+133.3%
Q1 2017$24,000
+166.7%
80,0000.0%0.00%
+200.0%
Q4 2016$9,000
+12.5%
80,0000.0%0.00%0.0%
Q3 2016$8,000
-20.0%
80,0000.0%0.00%
-50.0%
Q2 2016$10,000
-9.1%
80,0000.0%0.00%0.0%
Q1 2016$11,000
-21.4%
80,0000.0%0.00%0.0%
Q4 2015$14,000
-12.5%
80,0000.0%0.00%
-33.3%
Q3 2015$16,000
-23.8%
80,0000.0%0.00%0.0%
Q2 2015$21,000
-52.3%
80,0000.0%0.00%
-50.0%
Q1 2015$44,00080,0000.01%
Other shareholders
CANOPUS BIOPHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
HOLLENCREST CAPITAL MANAGEMENT 80,000$44,0000.01%
View complete list of CANOPUS BIOPHARMA INC shareholders